It must be obtained through diet or supplementation
While research into the subject continues, reviews have previously pointed to semaglutide in tablet form offering similar or better efficacy as well as similar tolerability to injectable versions
Panczenko-Kresowska B, Ziemlaski S, Rudnicki S, Wojtulewicz L, Przepirka M
p 7%, 18 years old with previous CVD, or 50 years old with an eGFR of 2559.9 ml/min/1.73 m 2 , and one or more additional CVD risk factors were recruited
Key concerns include hypoglycemia risk, cardiovascular strain, fluid retention (both medications can affect sodium/water balance), and potential for exaggerated appetite suppression